Incidence of appropriate anti-tachycardia therapies after elective generator replacement in patient with heart failure initially implanted with a defibrillator for primary prevention: Results of a meta-analysis.

[1]  G. Sanders,et al.  When Is It Safe Not to Reimplant an Implantable Cardioverter Defibrillator at the Time of Battery Depletion? , 2018, Cardiac electrophysiology clinics.

[2]  M. Biffi,et al.  Manufacturer change and risk of system-related complications after implantable cardioverter defibrillator replacement: physicians’ survey and data from the Detect Long-term Complications After Implantable Cardioverter Defibrillator Replacement Registry , 2017, Journal of cardiovascular medicine.

[3]  M. Costa,et al.  Who still remains at risk of arrhythmic death at time of implantable cardioverter‐defibrillator generator replacement? , 2017, Pacing and clinical electrophysiology : PACE.

[4]  P. Vardas,et al.  Cardiac resynchronization therapy (CRT) device replacement considerations: upgrade or downgrade? A complex decision in the current clinical setting , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[5]  P. Marino,et al.  Persistence of ICD indication at the time of replacement in patients with initial implant for primary prevention indication: Effect on subsequent ICD therapies , 2016, Indian pacing and electrophysiology journal.

[6]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[7]  Jonathan W. Waks,et al.  Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death , 2016, Circulation. Arrhythmia and electrophysiology.

[8]  A. León,et al.  Implantable Cardioverter-Defibrillators at End of Battery Life: Opportunities for Risk (Re)-Stratification in ICD Recipients. , 2016, Journal of the American College of Cardiology.

[9]  E. Guallar,et al.  Changes in Follow-Up Left Ventricular Ejection Fraction Associated With Outcomes in Primary Prevention Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Recipients. , 2015, Journal of the American College of Cardiology.

[10]  S. Solomon,et al.  Left Ventricular Ejection Fraction Normalization in Cardiac Resynchronization Therapy and Risk of Ventricular Arrhythmias and Clinical Outcomes: Results From the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT–CRT) Trial , 2014, Circulation.

[11]  C. Leclercq,et al.  Positive Response to Cardiac Resynchronization Therapy Reduces Arrhythmic Events After Elective Generator Change in Patients with Primary Prevention CRT‐D , 2014, Journal of cardiovascular electrophysiology.

[12]  S. Dixit,et al.  Appropriateness of primary prevention implantable cardioverter-defibrillators at the time of generator replacement: are indications still met? , 2014, Journal of the American College of Cardiology.

[13]  M. Josephson,et al.  Mortality risk following replacement implantable cardioverter-defibrillator implantation at end of battery life: results from the NCDR. , 2014, Heart rhythm.

[14]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[15]  Sharon-Lise Normand,et al.  Characteristics and Outcomes of Patients Receiving New and Replacement Implantable Cardioverter-Defibrillators: Results From the NCDR , 2013, Circulation. Cardiovascular quality and outcomes.

[16]  A. Kadish,et al.  Significance of follow-up left ventricular ejection fraction measurements in the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation trial (DEFINITE). , 2013, Heart rhythm.

[17]  I. Anand,et al.  Incidence of appropriate shock in implantable cardioverter-defibrillator patients with improved ejection fraction. , 2013, Journal of cardiac failure.

[18]  L. Shaw,et al.  Association Between Left Ventricular Ejection Fraction Post-Cardiac Resynchronization Treatment and Subsequent Implantable Cardioverter Defibrillator Therapy for Sustained Ventricular Tachyarrhythmias , 2013, Circulation. Arrhythmia and electrophysiology.

[19]  K. Wegscheider,et al.  Long-term benefit of implantable cardioverter/defibrillator therapy after elective device replacement: results of the INcidence free SUrvival after ICD REplacement (INSURE) trial--a prospective multicentre study. , 2013, European heart journal.

[20]  M. Chung,et al.  Cardiovascular Implantable Electronic Device Replacement Infections and Prevention: Results from the REPLACE Registry , 2012, Pacing and clinical electrophysiology : PACE.

[21]  Eugene Crystal,et al.  Predictors of Short-Term Complications After Implantable Cardioverter-Defibrillator Replacement: Results From the Ontario ICD Database , 2011, Circulation. Arrhythmia and electrophysiology.

[22]  M. Chung,et al.  Complication Rates Associated With Pacemaker or Implantable Cardioverter-Defibrillator Generator Replacements and Upgrade Procedures: Results From the REPLACE Registry , 2010, Circulation.

[23]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[24]  C. Schneider,et al.  ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. , 2008, European heart journal.

[25]  M. Link,et al.  Time‐Dependence of Appropriate Implantable Defibrillator Therapy in Patients with Ischemic Cardiomyopathy , 2008, Journal of cardiovascular electrophysiology.

[26]  Jacques Victor,et al.  Risk Factors Related to Infections of Implanted Pacemakers and Cardioverter-Defibrillators: Results of a Large Prospective Study , 2007, Circulation.

[27]  R. Berger,et al.  Are Implantable Cardioverter Defibrillator Shocks a Surrogate for Sudden Cardiac Death in Patients With Nonischemic Cardiomyopathy? , 2006, Circulation.

[28]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[29]  A. Kadish,et al.  DEFibrillators In Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE). , 2003, Cardiac electrophysiology review.

[30]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .